These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20118958)

  • 1. Daniel Vasella.
    Hughes B
    Nat Rev Drug Discov; 2010 Feb; 9(2):98. PubMed ID: 20118958
    [No Abstract]   [Full Text] [Related]  

  • 2. Hunting for predictive computational drug-discovery models.
    Snow CD
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):291-3. PubMed ID: 18588493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An audience with...Marc Cluzel.
    Cluzel M
    Nat Rev Drug Discov; 2010 Jan; 9(1):14. PubMed ID: 20043024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

  • 5. Innovative drug R&D in China.
    Qi J; Wang Q; Yu Z; Chen X; Wang F
    Nat Rev Drug Discov; 2011 May; 10(5):333-4. PubMed ID: 21532556
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical sciences in 2020.
    Crommelin D; Stolk P; Besançon L; Shah V; Midha K; Leufkens H
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract]   [Full Text] [Related]  

  • 7. Merck's recall of rofecoxib--a strategic perspective.
    Oberholzer-Gee F; Inamdar SN
    N Engl J Med; 2004 Nov; 351(21):2147-9. PubMed ID: 15548771
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescription for an ailing pharmaceutical industry.
    Demain AL
    Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
    [No Abstract]   [Full Text] [Related]  

  • 9. Back to the future.
    Offit P
    Expert Rev Vaccines; 2004 Apr; 3(2):107-8. PubMed ID: 15056035
    [No Abstract]   [Full Text] [Related]  

  • 10. Concerns raised over declining antiinfectives R&D.
    Fox JL
    Nat Biotechnol; 2003 Nov; 21(11):1255-6. PubMed ID: 14595340
    [No Abstract]   [Full Text] [Related]  

  • 11. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escaping the pincer.
    Nat Rev Drug Discov; 2009 Dec; 8(12):915. PubMed ID: 19967796
    [No Abstract]   [Full Text] [Related]  

  • 13. Jean-Jacques Garaud. Interview by Bethan Hughes.
    Garaud JJ
    Nat Rev Drug Discov; 2010 Aug; 9(8):588. PubMed ID: 20671757
    [No Abstract]   [Full Text] [Related]  

  • 14. A status report on neuroscience research, without grade inflation.
    Johnston SC; Hauser SL
    Ann Neurol; 2006 Dec; 60(6):A9-11. PubMed ID: 17192939
    [No Abstract]   [Full Text] [Related]  

  • 15. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug research--a change of paradigms.
    Müllner S
    Arzneimittelforschung; 1997 Jan; 47(1):105. PubMed ID: 9037454
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical research: outlook from industry.
    Echols R
    Clin Perform Qual Health Care; 1996; 4(2):113-4. PubMed ID: 10156942
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug life-cycle technologies.
    Fleming E; Ma P
    Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
    [No Abstract]   [Full Text] [Related]  

  • 19. Science, medicine and... the markets.
    Pawlotsky JM
    J Hepatol; 2006 Sep; 45(3):341-2. PubMed ID: 16854496
    [No Abstract]   [Full Text] [Related]  

  • 20. A changing drug supply.
    Nature; 2007 Feb; 445(7127):460. PubMed ID: 17268432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.